Trials / Conditions / Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
3 registered clinical trials studyying Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer NCT03744793 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer NCT03912818 | Stanford University | Phase 2 |
| Active Not Recruiting | Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot NCT02812420 | M.D. Anderson Cancer Center | EARLY_Phase 1 |